MedTrace Logo

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection

NCT00547495 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 343

Last updated 2007-10-22

No results posted yet for this study

Summary

Study to determine how safe and effective tadalafil is for Japanese men taking it when they need to get and keep an erection.

Conditions

  • Impotence

Interventions

DRUG

tadalafil

5 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

placebo

placebo tablet taken by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

tadalafil

10 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

DRUG

tadalafil

20 mg tadalafil tablet, by mouth, as needed, no more than 1 dose per day, for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2004-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00547495 on ClinicalTrials.gov